Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection

Sputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis

(2012) Scott D. Sagel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

(2012) Bruno François et al.   CRITICAL CARE MEDICINE

Viral infections trigger exacerbations of cystic fibrosis in adults and children: Figure 1–

(2012) Peter A.B. Wark et al.   EUROPEAN RESPIRATORY JOURNAL

Risk factors for rate of decline in FEV1 in adults with cystic fibrosis

(2012) Michael W. Konstan et al.   Journal of Cystic Fibrosis

Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint

(2011) D.R. VanDevanter et al.   Journal of Cystic Fibrosis

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis

(2011) Nicole Mayer-Hamblett et al.   PEDIATRIC PULMONOLOGY

Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution

(2011) Gregory S. Sawicki et al.   PEDIATRIC PULMONOLOGY

Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells

(2011) S. S. Chattoraj et al.   THORAX

The Changing Microbial Epidemiology in Cystic Fibrosis

(2010) J. J. LiPuma   CLINICAL MICROBIOLOGY REVIEWS

Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis

(2009) Theresa A. Laguna et al.   CHEST

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

(2009) George Z. Retsch-Bogart et al.   CHEST

Role of Pseudomonas aeruginosa type III effectors in disease

(2009) Joanne Engel et al.   CURRENT OPINION IN MICROBIOLOGY

Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa

(2009) H. Mikkelsen et al.   MICROBIOLOGY-SGM

Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis

(2008) Karen S. McCoy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Targeting neutrophil elastase in cystic fibrosis

(2008) Emer Kelly et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection

(2008) Manu Jain et al.   Translational Research

A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis

(2007) Konstantinos A. Papas et al.   Journal of Cystic Fibrosis